253 related articles for article (PubMed ID: 9239407)
1. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.
Weinberg DS; Ruggeri B; Barber MT; Biswas S; Miknyocki S; Waldman SA
J Clin Invest; 1997 Aug; 100(3):597-603. PubMed ID: 9239407
[TBL] [Abstract][Full Text] [Related]
2. Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma.
Goetze JP; Nielsen FC; Burcharth F; Rehfeld JF
Cancer; 2000 Jun; 88(11):2487-94. PubMed ID: 10861424
[TBL] [Abstract][Full Text] [Related]
3. Human cholecystokinin-A receptor is not an oncofetal protein.
Weinberg DS; So C; Ruggeri B; Biswas S; Barber M; Waldman S
Dig Dis Sci; 2000 Mar; 45(3):538-43. PubMed ID: 10749330
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study.
Monstein HJ; Nylander AG; Salehi A; Chen D; Lundquist I; Håkanson R
Scand J Gastroenterol; 1996 Apr; 31(4):383-90. PubMed ID: 8726308
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer.
Moonka R; Zhou W; Bell RH
J Gastrointest Surg; 1999; 3(2):134-40. PubMed ID: 10457335
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
8. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor.
Funakoshi A; Miyasaka K; Shinozaki H; Masuda M; Kawanami T; Takata Y; Kono A
Biochem Biophys Res Commun; 1995 May; 210(3):787-96. PubMed ID: 7539259
[TBL] [Abstract][Full Text] [Related]
9. Does neoplastic cholecystokinin expression reflect the embryonal pattern of the protein? A study in human pancreas.
Tamiolakis D; Venizelos I; Simopoulos C; Lambropoulou M; Kotini A; Jivannakis T; Alexiadis G; Boglou P; Papadopoulos N
Acta Medica (Hradec Kralove); 2004; 47(2):101-5. PubMed ID: 15446358
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin A and B receptor mRNA expression in human pancreas.
Nishimori I; Kamakura M; Fujikawa-Adachi K; Nojima M; Onishi S; Hollingsworth MA; Harris A
Pancreas; 1999 Aug; 19(2):109-13. PubMed ID: 10438155
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines.
Monstein HJ; Ohlsson B; Axelson J
Scand J Gastroenterol; 2001 Jul; 36(7):738-43. PubMed ID: 11444473
[TBL] [Abstract][Full Text] [Related]
12. Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue.
Reubi JC; Waser B; Gugger M; Friess H; Kleeff J; Kayed H; Büchler MW; Laissue JA
Gastroenterology; 2003 Jul; 125(1):98-106. PubMed ID: 12851875
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of cholecystokinin-A- receptor antagonist on human pancreatic exocrine secretion. Localization of CCK-A receptor in the human duodenum.
Funakoshi A; Fukamizu Y; Miyasaka K
Digestion; 1999; 60 Suppl 1():75-80. PubMed ID: 10026437
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical examination of cholecystokinin and gastrin receptors (CCK-2/gastrin-R) expression in normal and exocrine cancerous human pancreatic tissues.
Sellam F; Harir N; Khaled MB; Mrabent NM; Belkralladi H; Tou A; Diaf M; Salah R; Moulessehoul S
Pancreatology; 2015; 15(6):661-6. PubMed ID: 26520651
[TBL] [Abstract][Full Text] [Related]
15. Activation of phospholipase C by cholecystokinin receptor subtypes with different G-protein-coupling specificities in hormone-secreting pancreatic cell lines.
Paulssen RH; Fraeyman N; Florholmen J
Biochem Pharmacol; 2000 Sep; 60(6):865-75. PubMed ID: 10930542
[TBL] [Abstract][Full Text] [Related]
16. Expression of receptors for gut peptides in pancreata of BOP-treated and control hamsters.
Tang C; Biemond I; Appel MJ; Visser CJ; Woutersen RA; Lamers CB
Carcinogenesis; 1996 Oct; 17(10):2171-5. PubMed ID: 8895485
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of a long-acting somatostatin analogue on EGF-stimulated cell proliferation in Capan-2 cells.
Burghardt B; Barabás K; Marcsek Z; Flautner L; Gress TM; Varga G
J Physiol Paris; 2000; 94(1):57-62. PubMed ID: 10761690
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
19. A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3'-splicing site leading to retention of the fourth intron.
Ding WQ; Kuntz SM; Miller LJ
Cancer Res; 2002 Feb; 62(3):947-52. PubMed ID: 11830556
[TBL] [Abstract][Full Text] [Related]
20. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
